Recent Publications by Oncotest GmbH: |
Mansouramycins A-D, Cytotoxic Isoquinolinequinones from a Marine Streptomycete (1).
Chemical screening of the ethyl acetate extract from the marine-derived... | 20th November, 2009
| Institute of Organic and Biomolecular Chemistry, University of Gottingen,
| J Nat Prod. 2009 Nov 18.
DOI Direct Link |
Tissue microarrays of human tumor xenografts: characterization of proteins involved in migration and angiogenesis for applications in the development of targeted anticancer agents.
As new target-directed anticancer agents emerge, preclinical efficacy... | 7th February, 2009
| Institute for Experimental Oncology, Oncotest GmbH, Freiburg, Germany.
| Cancer Genomics Proteomics. 2008 Sep-Oct;5(5):263-73.
|
Molecular analysis of xenograft models of human cancer cachexia--possibilities for therapeutic intervention.
Approximately 50% of all cancer patients develop cachexia, a... | 6th December, 2007
| Institute for Experimental Oncology, Oncotest GmbH, Am Flughafen 12-14,
| Cancer Genomics Proteomics. 2007 May-Jun;4(3):223-31.
|
Gene signatures developed from patient tumor explants grown in nude mice to predict tumor response to 11 cytotoxic drugs.
Patient tumor explants established subcutaneously in serial passage in... | 6th December, 2007
| Oncotest GmbH, Institute for Experimental Oncology, Am Flughafen 12-14,
| Cancer Genomics Proteomics. 2007 May-Jun;4(3):197-209.
|
Gene signature-based prediction of tumor response to cyclophosphamide.
Cyclophosphamide (CY) is a clinically used cytotoxic agent that is... | 6th December, 2007
| Oncotest GmbH, Institute for Experimental Oncology, Am Flughafen 12-14,
| Cancer Genomics Proteomics. 2007 May-Jun;4(3):187-95.
|
Microarrays of 41 human tumor cell lines for the characterization of new molecular targets: expression patterns of cathepsin B and the transferrin receptor.
In recent years the use of the microarray technology has allowed the... | 23rd May, 2007
| Institute for Experimental Oncology, Oncotest GmbH, Freiburg, Germany.
| Oncology. 2006;71(1-2):86-94. Epub 2007 Mar 8.
DOI Direct Link |
Cytotoxic activity and absence of tumor growth stimulation of standardized mistletoe extracts in human tumor models in vitro.
Mistletoe extracts are widely used in complementary and alternative cancer... | 30th March, 2007
| Oncotest GmbH, Institute for Experimental Oncology, Am Flughafen 12, 79018
| Anticancer Res. 2007 Jan-Feb;27(1A):223-33.
|
Arugosins G and H: prenylated polyketides from the marine-derived fungus Emericellanidulans var. acristata.
The fungus Emericella nidulans var. acristata was isolated as an endophyte... | 21st September, 2006
| Institute for Pharmaceutical Biology, University of Bonn, Nussallee 6,
| J Nat Prod. 2006 Jul;69(7):995-1000.
DOI Direct Link |
Absence of tumor growth stimulation in a panel of 26 human tumor cell lines by mistletoe (Viscum album L.) extracts Iscador in vitro.
Mistletoe (Viscum album L.) extracts exhibit antitumor activity based on... | 16th September, 2006
| Oncotest GmbH, Institut fur experimentelle Onkologie, Freiburg, Germany.
| Arzneimittelforschung. 2006 Jun;56(6A):435-40.
|
In-vitro anti-tumor activity studies of bridged and unbridged benzyl-substituted titanocenes.
The benzyl-substituted ansa-titanocenes... | 17th February, 2006
| Oncotest GmbH, Institute of Experimental Oncology, Freiburg, Germany.
| Anticancer Drugs. 2005 Nov;16(10):1091-8.
|
Clonogenic assay with established human tumour xenografts: correlation of in vitro to in vivo activity as a basis for anticancer drug discovery.
Pluripotent cells can be grown in clonogenic assays. The tumour stem-cell... | 27th May, 2004
| Institute for Experimental Oncology, Oncotest GmbH, Am Flughafen 12-4,
| Eur J Cancer. 2004 Apr;40(6):802-20.
DOI Direct Link |
Absence of tumor growth stimulation in a panel of 16 human tumor cell lines by mistletoe extracts in vitro.
Extracts of Viscum album (mistletoe) are widely used as complementary... | 18th December, 2002
| Institute of Experimental Oncology, Oncotest GmbH, 79108 Freiburg,
| Anticancer Drugs. 2002 Apr;13(4):373-9.
|
